This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Related articles in BJP
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by SCOTT, J.
Right arrow Articles by HAYHURST, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SCOTT, J.
Right arrow Articles by HAYHURST, H.
The British Journal of Psychiatry (2003) 182: 221-227
© 2003 The Royal College of Psychiatrists

Use of cognitive therapy for relapse prevention in chronic depression

Cost-effectiveness study

JAN SCOTT, FRCPsych

Institute of Psychiatry, London

STEPHEN PALMER, PhD

Centre for Health Economics, University of York

EUGENE PAYKEL, FRCPsych

Department of Psychiatry, University of Cambridge

JOHN TEASDALE, PhD

MRC Cognition and Brain Sciences Unit, Cambridge

HAZEL HAYHURST, PhD

Department of Psychiatry, University of Cambridge, UK

Correspondence: Jan Scott, PO Box 96, Department of Psychological Medicine, Institute of Psychiatry, De Crespigny Park, Denmark Hill, London SE5 8AF, UK. E-mail: j.scott{at}iop.kcl.ac.uk

Declaration of interest This research was supported by a grant from the Medical Research Council.

Background There is a lack of data on the cost-effectiveness of relapse prevention in depression.

Method A total of 158 subjects with partially remitted major depression despite adequate clinical treatment were randomly allocated to cognitive therapy in addition to antidepressants and clinical management v. antidepressants and clinical management alone. Relapse rates and health care resource utilisation were measured prospectively over 17 months.

Results Cumulative relapse rates in the cognitive therapy group were significantly lower than in the control group (29% v. 47%). The incremental cost incurred in subjects receiving cognitive therapy over 17 months (£779; 95% CI £387-£1170) was significantly lower than the overall mean costs of cognitive therapy (£1164; 95% CI £1084-£1244). The incremental cost-effectiveness ratio ranged from £4328 to £5027 per additional relapse prevented.

Conclusions In individuals with depressive symptoms that are resistant to standard treatment, adjunctive cognitive therapy is more costly but more effective than intensive clinical treatment alone.


Related articles in BJP:

Highlights of this issue
SUKHI SHERGILL
BJP 2003 182: 185-a11. [Full Text]  



This article has been cited by other articles:


Home page
 Eval Health ProfHome page
P. G. Stiles, R. A. Boothroyd, K. Dhont, P. F. Beiler, and A. E. Green
Adherence to Practice Guidelines, Clinical Outcomes, and Costs Among Medicaid Enrollees With Severe Mental Illnesses
Eval Health Prof, March 1, 2009; 32(1): 69 - 89.
[Abstract] [PDF]

Home page
 Br. J. PsychiatryHome page
J. Simon, S. Pilling, R. Burbeck, and D. Goldberg
Treatment options in moderate and severe depression: decision analysis supporting a clinical guideline
The British Journal of Psychiatry, December 1, 2006; 189(6): 494 - 501.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. PsychiatryHome page
R. Araya, T. Flynn, G. Rojas, R. Fritsch, and G. Simon
Cost-Effectiveness of a Primary Care Treatment Program for Depression in Low-Income Women in Santiago, Chile
Am J Psychiatry, August 1, 2006; 163(8): 1379 - 1387.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
F. SMIT, G. WILLEMSE, M. KOOPMANSCHAP, S. ONRUST, P. CUIJPERS, and A. BEEKMAN
Cost-effectiveness of preventing depression in primary care patients: Randomised trial
The British Journal of Psychiatry, April 1, 2006; 188(4): 330 - 336.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
E. FENWICK and S. BYFORD
A guide to cost-effectiveness acceptability curves
The British Journal of Psychiatry, August 1, 2005; 187(2): 106 - 108.
[Abstract] [Full Text] [PDF]

Home page
 FocusHome page
L. J. Fochtmann and A. J. Gelenberg
Guideline Watch: Practice Guideline for the Treatment of Patients With Major Depressive Disorder, 2nd Edition
Focus, January 1, 2005; 3(1): 34 - 42.
[Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
OTHER ARTICLES NOTED (25 Apr 2003 to 18 Jul 2003)
Evid. Based Nurs., October 1, 2003; 6(4): e1 - 12.
[Full Text]

Home page
 National Institute Economic ReviewHome page
S. Byford and T. Sefton
Economic Evaluation of Complex Health and Social Care Interventions
National Institute Economic Review, October 1, 2003; 186(1): 98 - 108.
[Abstract] [PDF]

Home page
 Evid. Based Ment. HealthHome page
H. Christensen
Adjunctive cognitive therapy is more effective, but more costly, than standard clinical management for relapse prevention in depression
Evid. Based Ment. Health, August 1, 2003; 6(3): 85 - 85.
[Full Text] [PDF]

Home page
 Psychiatr. Serv.Home page
J. Mark
Psychopharmacology Plus Psychotherapy for Depression Treatment
Psychiatr Serv, July 1, 2003; 54(7): 1042 - 1042.
[Full Text] [PDF]

Home page
 BMJHome page
Minerva
BMJ, March 22, 2003; 326(7390): 668 - 668.
[Full Text] [PDF]